| Literature DB >> 30583692 |
Jitrapa Kerdsuknirun1, Virunpat Vilaichone, Ratha-Korn Vilaichone.
Abstract
Objective: Hepatocellular carcinoma (HCC) is the fatal cancer worldwide. Spontaneously Rupture remains important complication of HCC. The incidence of spontaneous HCC rupture was high in ASEAN but limited studies were reported. The aim of this study was to evaluate predictors and overall survival of ruptured HCC in tertiary care center in Thailand.Entities:
Keywords: Hepatocellular carcinoma; Ruptured; Thailand
Mesh:
Year: 2018 PMID: 30583692 PMCID: PMC6428545 DOI: 10.31557/APJCP.2018.19.12.3629
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
Demographic Data of All Patients
| Total (n=333) | ruptured vs. non-ruptured HCC | p-value | ||
|---|---|---|---|---|
| Rupture (n=a51) | non-rupture (n=282) | |||
| Sex | ||||
| Male | 263 (79%) | 44 (86.27%) | 219 (77.66%) | 0.165 |
| Female | 70 (21%) | 7 (13.73%) | 63 (22.34%) | 0.165 |
| Age | 59.9±12.3 | 55.25 ± 12.16 | 60.73 ± 12.11 | 0.003 |
| DM | 69 (20.7%) | 11 (21.57%) | 58 (20.57%) | 0.871 |
| Symptoms | ||||
| asymptomatic | 105 (31.5%) | 6 (11.76%) | 99 (35.11%) | 0.001* |
| abdominal discomfort | 150 (45%) | 39 (76.47%) | 111 (39.36%) | <0.001* |
| weight loss | 117 (35.1%) | 17 (33.33%) | 100 (35.46%) | 0.77 |
| jaundice | 9 (2.7%) | 1 (1.96%) | 8 (2.84%) | 0.723 |
| malaise/fatigue | 16 (4.8%) | 3 (5.88%) | 13 (4.61%) | 0.696 |
| anemic symptoms | 9 (2.7%) | 7 (13.73%) | 2 (0.71%) | <0.001* |
| GI bleed | 10 (3%) | 0 (0%) | 10 (3.55%) | 0.371 |
| fever | 8 (2.4%) | 1 (1.96%) | 7 (2.48%) | 1 |
| Physical examination | ||||
| ascites | 11 (3.3%) | 4 (7.84%) | 7 (2.48%) | 0.049* |
| peritonitis | 3 (0.9%) | 3 (5.88%) | 0 (0%) | <0.001* |
| hepatomegaly | 1 (0.3%) | 0 (0%) | 1 (0.35%) | 0.67 |
| splenomegaly | 2 (0.6%) | 1 (1.96%) | 1 (0.35%) | 0.172 |
| Cirrhosis | 330 (99.1%) | 50 (98.04%) | 280 (99.29%) | 0.384 |
| Cause of CLD | ||||
| alcohol | 105 (31.5%) | 17 (33.33%) | 88 (31.21%) | 0.764 |
| HBV | 153 (45.9%) | 25 (49.02%) | 128 (45.39%) | 0.632 |
| HCV | 77 (23.1%) | 8 (15.69%) | 69 (24.47%) | 0.171 |
| NASH | 13 (3.9%) | 2 (3.92%) | 11 (3.9%) | 0.994 |
| cryptogenic | 15 (4.5%) | 2 (3.92%) | 13 (4.61%) | 0.827 |
| Risk factors | ||||
| active alcohol | 64 (19.8%) | 11 (21.57%) | 55 (19.5%) | 0.734 |
| HBeAg +ve | 31/153 (20.3%) | 4 (19.05%) | 27 (26.73%) | 0.695 |
| antiHBe +ve | 93/153 (60.8%) | 18 (85.71%) | 75 (74.26%) | 0.203 |
| HBV VL (cp/mL) | ||||
| ≤100,000 | 88/153 (57.5%) | 14 (66.67%) | 74 (70.48%) | 0.728 |
| >100,000 | 38/153 (24.8%) | 7 (33.33%) | 31 (29.52%) | 0.728 |
| CHC S/P previous Rx | 11 (3.3%) | 0 (0%) | 11 (16.18%) | 0.152 |
| Cure | 0 (0%) | 5 (45.45%) | 0.338 | |
| fail | 0 (0%) | 6 (54.55%) | 0.293 | |
| HCC BCLC stage | ||||
| A | 88 (26.4%) | 2 (3.92%) | 86 (30.5%) | <0.001* |
| B | 139 (41.7%) | 26 (50.98%) | 113 (40.07%) | 0.146 |
| C | 70 (21%) | 14 (27.45%) | 56 (19.86%) | 0.221 |
| D | 36 (10.8%) | 9 (17.65%) | 27 (9.57%) | 0.088 |
| Mean of max. size of mass(cm) | 7.1±5 (1-22) | 10.29 ± 5.7 | 6.47 ± 4.68 | <0.001* |
| Major vessel thrombosis | 75 (22.5%) | 15 (57.69%) | 60 (71.43%) | 0.201 |
| Metastasis | 32 (9.6%) | 9 (17.65%) | 23 (8.16%) | 0.034* |
| Child-Pugh score | ||||
| A | 163 (48.9%) | 16 (31.37%) | 147 (52.5%) | 0.006* |
| B | 150 (45%) | 31 (60.78%) | 119 (42.5%) | 0.014* |
| C | 18 (5.4%) | 4 (7.84%) | 14 (5%) | 0.403 |
| MELD score | 11±4.9 | 11.86 ± 4.21 | 10.83 ± 5.05 | 0.171 |
| MELD Na score | 13.5±5.7 | 14.59 ± 5.14 | 13.26 ± 5.77 | 0.124 |
| Signs of PHT ascites | ||||
| no | 216 (64.9%) | 24 (47.06%) | 192 (68.33%) | 0.004* |
| controlled | 110 (33%) | 27 (52.94%) | 83 (29.54%) | 0.001* |
| refractory | 6 (1.8%) | 0 (0%) | 6 (2.14%) | 0.293 |
| varices | 138 (41.4%) | 15 (29.41%) | 123 (43.77%) | 0.058 |
| splenomegaly | 180 (54.1%) | 23 (45.1%) | 157 (55.87%) | 0.163 |
| Laboratory tests | ||||
| WBC (109/L) | 8723.53 ± 4092.66 | 7390.43 ± 4608.74 | 0.054 | |
| Hct (%) | 35.24 ± 7.22 | 51.64 ± 260.87 | 0.654 | |
| Plt (109/L) | 183.7±110.1 | 226.92 ± 130.83 | 175.88 ± 104.32 | 0.002* |
| Cr (mg/dL) | 1.19 ± 0.69 | 1.11 ± 0.85 | 0.521 | |
| AST (U/L) | 187.33 ± 207.69 | 108.95 ± 123.47 | 0.011* | |
| ALT (U/L) | 82.84 ± 65.28 | 73.15 ± 47.76 | 0.315 | |
| ALP (U/L) | 186.59 ± 111.78 | 187.95 ± 128.52 | 0.944 | |
| TB (mg/dL) | 1.9±3.6 | 2.18 ± 3.35 | 1.82 ± 3.68 | 0.507 |
| Alb (g/dL) | 2.5 ± 0.55 | 2.43 ± 0.49 | 0.379 | |
| INR | 1.22 ± 0.22 | 1.61 ± 5.98 | 0.644 | |
| AFP (ng/mL) | ||||
| 0-20 | 120 (36%) | 12 (23.53%) | 108 (38.3%) | 0.043* |
| 20.1-200 | 78 (23.4%) | 8 (15.69%) | 70 (24.82%) | 0.156 |
| >200 | 135 (40.5%) | 31 (60.78%) | 104 (36.88%) | 0.001* |
Values presented as frequency (%) and mean ± SD. P-value corresponds to Independent’s t test (Continuous data) and Chi square test or Fisher’s exact test (Categorical data).
Predictive Factors for Ruptured HCC
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Crude OR | p-value | Adjusted OR (95%CI) | p-value | |
| Male | 1.81 (0.76, 4.98) | 0.165 | ||
| Age | 0.96 (0.94, 0.99) | 0.004* | 0.96 (0.93, 0.99) | 0.02* |
| Symptoms | ||||
| abdominal discomfort | 5.01 (2.43, 10.93) | <0.001* | 3.47 (1.26, 9.6) | 0.016* |
| anemic symptoms | 22.27 (4, 222.79) | <0.001* | 54.51 (7.09, 418.89) | <0.001* |
| Cirrhosis | 0.36 (0.02, 21.49) | 0.384 | ||
| Child-Pugh score | ||||
| B, C | 2.42 (1.28, 4.57) | 0.007* | 2.62 (1.09, 6.31) | 0.031* |
| Signs of PHT | ||||
| ascites | 2.43 (1.33, 4.44) | 0.004* | 0.96 (0.43, 2.14 | 0.925 |
Values presented as Odds ratio (OR) and 95% Confident Interval (CI.). P-value corresponds to Logistic regression analysis.
Figure 1Overall Survival